UK markets closed

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
25.94+0.48 (+1.89%)
At close: 04:00PM EDT
26.29 +0.35 (+1.35%)
After hours: 07:56PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
360,911
377,709
60,920
51,844
24
-
Operating expenses
Research development
422,553
437,381
311,594
387,087
103,179
-
Selling general and administrative
120,047
116,813
87,805
57,222
29,605
-
Total operating expenses
542,600
554,194
399,399
444,309
132,784
-
Operating income or loss
-181,689
-176,485
-338,479
-392,465
-132,760
-
Interest expense
-
-
-
-
-
187
Total other income/expenses net
-245
-1,352
63,004
21,836
-62,883
-
Income before tax
-133,370
-131,161
-260,178
-370,638
-194,592
-
Income tax expense
-
1,366
3,410
0
0
-
Income from continuing operations
-134,736
-132,527
-289,088
-370,638
-194,592
-
Net income
-134,736
-132,527
-289,088
-370,638
-194,592
-
Net income available to common shareholders
-134,736
-132,527
-289,088
-370,638
-195,869
-
Basic EPS
-4.17
-1.72
-4.13
-5.77
-4.19
-
Diluted EPS
-4.17
-1.72
-4.13
-5.77
-4.19
-
Basic average shares
74,623
77,152
70,015
64,228
46,733
-
Diluted average shares
74,623
77,152
70,015
64,228
46,733
-